A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

Simon Wan Yau Ming,1 John Haughney,2 Dermot Ryan,3 Iain Small,4 Federico Lavorini,5 Alberto Papi,6 Dave Singh,7 David MG Halpin,8 John R Hurst,9 Shishir Patel,10 Matthias Ochel,10 Janwillem Kocks,1,11,12 Victoria Carter,1 Antony Hardjojo,1 David B Price1,2 1Observational and Pragmatic Research Insti...

Full description

Bibliographic Details
Main Authors: Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:International Journal of COPD
Subjects:
metered dose inhaler
dry powder inhaler
chronic obstructive pulmonary disease
treatment efficacy
cost effectiveness
Online Access:https://www.dovepress.com/a-comparison-of-the-real-life-clinical-effectiveness-of-the-leading-li-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/a-comparison-of-the-real-life-clinical-effectiveness-of-the-leading-li-peer-reviewed-article-COPD

Similar Items